Volume 81, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The sensitivities and specificities of IgG-ELISA and IgG flow cytometry based techniques using different species were determined using sera collected from 40 cutaneous or visceral leishmaniasis patients. The flow cytometry technique, using promastigote parasite forms, performed better than total soluble extract IgG-ELISA. At the species level, the use of and as antigens in enzyme linked immunosorbent assay (ELISA) decreased the overall sensitivity. To assess the specificity of these tests, sera from malaria, toxoplasmosis, amoebiasis, schistosomiasis, and leprosy patients were used. We also included sera from non-infected endemic individuals. The cutaneous species displayed a decreased specificity in both assays. Although more sensitive, flow cytometry using promastigote parasite forms generally presented lower levels of specificity when compared with total extract of IgG-ELISA. Overall, the results of the study show the potential of IgG flow cytometry for the diagnosis of leishmaniasis. Although highly sensitive, a refinement of the flow cytometry method should be performed to improve the overall specificity.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Evans TG, 1993. Leishmaniasis. Infect Dis Clin North Am 7 : 527–546. [Google Scholar]
  2. Escobar MA, Martinez F, Scott Smith D, Palma GI, 1992. American cutaneous and mucocutaneous leishmaniasis (tegumentary): a diagnostic challenge. Trop Doct 22 : 69–78. [Google Scholar]
  3. Spira AM, 2003. Assessment of travellers who return home ill. Lancet 362 : 83–84. [Google Scholar]
  4. Herwaldt BL, 1999. Leishmaniasis. Lancet 354 : 1191–1199. [Google Scholar]
  5. Reithinger R, Dujardin JC, 2007. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 45 : 21–25. [Google Scholar]
  6. Schallig HD, Schoone GJ, Kroon CC, Hailu A, Chappuis F, Veeken H, 2001. Development and application of “simple” diagnostic tools for visceral leishmaniasis. Med Microbiol Immunol (Berl) 190 : 69–71. [Google Scholar]
  7. Schoone GJ, Hailu A, Kroon CC, Nieuwenhuys JL, Schallig HD, Oskam L, 2001. A fast agglutination screening test (FAST) for the detection of anti- Leishmania antibodies. Trans R Soc Trop Med Hyg 95 : 400–401. [Google Scholar]
  8. Noya O, Patarroyo ME, Guzmán F, Alarcón de Noya B, 2003. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci 4 : 299–308. [Google Scholar]
  9. Rocha RD, Gontijo CM, Eloi-Santos SM, Teixeira Carvalho A, Correa-Oliveira R, Marques MJ, Genaro O, Mayrink W, Martins-Filho OA, 2002. Anti-live Leishmania (Viannia) braziliensis promastigote antibodies, detected by flow cytometry, to identify active infection in american cutaneous leishmaniasis. Rev Soc Bras Med Trop 35 : 551–562. [Google Scholar]
  10. Singh S, Dey A, Sivakumar R, 2005. Applications of molecular methods for Leishmania control. Expert Rev Mol Diagn 5 : 251–265. [Google Scholar]
  11. Santarém N, Tomás A, Ouaissi A, Tavares J, Ferreira N, Manso A, Campino L, Correia JM, Cordeiro-da-Silva A, 2005. Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Lett 101 : 18–23. [Google Scholar]
  12. Silvestre R, Santarém N, Cunha J, Cardoso L, Nieto J, Carrillo E, Moreno J, Cordeiro-da-Silva A, 2008. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amas-tigote-flow cytometry. Vet Parasitol 158 : 23–30. [Google Scholar]
  13. van der Meide WF, Sabajo LO, Jensema AJ, Peekel I, Faber WR, Schallig HD, Fat RF, 2009. Evaluation of treatment with pent-amidine for cutaneous leishmaniasis in Suriname. Int J Dermatol 48 : 52–58. [Google Scholar]
  14. Dantas-Torres F, 2006. Leishmania infantum versus Leishmania chagasi: do not forget the law of priority. Mem Inst Oswaldo Cruz 101 : 117–118. [Google Scholar]
  15. Minodier P, Piarroux R, Gambarelli F, Joblet C, Dumon H, 1997. Rapid identification of causative species in patients with Old World leishmaniasis. J Clin Microbiol 35 : 2551–2555. [Google Scholar]
  16. Shamsuzzaman SM, Furuya M, Choudhury AK, Korenaga M, HashiguchiY,2000. Characterization of Bangladeshi Leishmania isolated from kala-azar patients by isoenzyme electrophoresis. Parasitol Int 49 : 139–145. [Google Scholar]
  17. Zemzoumi K, Sereno D, François C, Guilvard E, Lemesre JL, Ouaissi A, 1998. Leishmania major: cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family. Biol Cell 90 : 239–245. [Google Scholar]
  18. Zweig MH, Campbell G, 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 : 561–577. [Google Scholar]
  19. Swets JA, 1988. Measuring the accuracy of diagnostic systems. Science 240 : 1285–1293. [Google Scholar]
  20. Garin YJ, Meneceur P, Pratlong F, Dedet JP, Derouin F, Lorenzo F, 2005. A2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene. BMC Infect Dis 5 : 18. [Google Scholar]
  21. Moody SF, 1993. Molecular variation in Leishmania. Acta Trop 53 : 185–204. [Google Scholar]
  22. Requena JM, Alonso C, Soto M, 2000. Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today 16 : 246–250. [Google Scholar]
  23. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R, Anupama A, Apostolou Z, Attipoe P, Bason N, Bauser C, Beck A, Beverley SM, Bianchettin G, Borzym K, Bothe G, Bruschi CV, Collins M, Cadag E, Ciarloni L, Clayton C, Coulson RM, Cronin A, Cruz AK, Davies RM, De Gaudenzi J, Dobson DE, Duesterhoeft A, Fazelina G, Fosker N, Frasch AC, Fraser A, Fuchs M, Gabel C, Goble A, Goffeau A, Harris D, Hertz-Fowler C, Hilbert H, Horn D, Huang Y, Klages S, Knights A, Kube M, Larke N, Litvin L, Lord A, Louie T, Marra M, Masuy D, Matthews K, Michaeli S, Mottram JC, Müller-Auer S, Munden H, Nelson S, Norbertczak H, Oliver K, O’neil S, Pentony M, Pohl TM, Price C, Purnelle B, Quail MA, Rabbinowitsch E, Reinhardt R, Rieger M, Rinta J, Robben J, Robertson L, Ruiz JC, Rutter S, Saunders D, Schäfer M, Schein J, Schwartz DC, Seeger K, Seyler A, Sharp S, Shin H, Sivam D, Squares R, Squares S, Tosato V, Vogt C, Volckaert G, Wambutt R, Warren T, Wedler H, Woodward J, Zhou S, Zimmermann W, Smith DF, Blackwell JM, Stuart KD, Barrell B, Myler PJ, 2005. The genome of the kinetoplastid parasite, Leishmania major. Science 309 : 436–442. [Google Scholar]
  24. Stevens JR, Noyes HA, Schofield CJ, Gibson W, 2001. The molecular evolution of Trypanosomatidae. Adv Parasitol 48 : 1–56. [Google Scholar]
  25. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey A, Aslett M, Kerhornou A, Ivens A, Fraser A, Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance Z, Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge A, Jeffares D, Depledge DP, Oyola SO, Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith DF, Berriman M, 2007. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39 : 839–847. [Google Scholar]
  26. Lynn MA, McMaster WR, 2008. Leishmania: conserved evolution-diverse diseases. Trends Parasitol 24 : 103–105. [Google Scholar]
  27. Rocha RD, Gontijo CM, Elói-Santos SM, Teixeira-Carvalho A, Corrêa-Oliveira R, Ferrari TC, Marques MJ, Mayrink W, Martins-Filho AO, 2006. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis. Trop Med Int Health 11 : 156–166. [Google Scholar]
  28. Pissinate JF, Gomes IT, Peruhype-Magalhães V, Dietze R, Martins-Filho OA, Lemos EM, 2008. Upgrading the flow-cytometric analysis of anti- Leishmania immunoglobulins for the diagnosis of American tegumentary leishmaniasis. J Immunol Methods 336 : 193–202. [Google Scholar]
  29. Junqueira Pedras M, Orsini M, Castro M, Passos VM, Rabello A, 2003. Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis. Diagn Microbiol Infect Dis 47 : 477–485. [Google Scholar]

Data & Media loading...

  • Received : 03 Sep 2008
  • Accepted : 20 Apr 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error